» Articles » PMID: 75244

Suppression of Murine Leukaemia Virus Production by Ouabain and Interferon in Mouse Cells

Overview
Journal J Gen Virol
Specialty Microbiology
Date 1978 Feb 1
PMID 75244
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Ouabain markedly inhibited the growth of the mouse cell lines K3b and JLS-V9 and the production of murine leukaemia virus (MuLV) in them. The inhibition of MuLV production was abolished by exposing the cells to normal medium or by adding a high concentration (43 mM) of K+ ions to the ouabain-containing medium. MuLV production was reduced by ouabain more rapidly than host cell directed protein synthesis. After treatment of cells with ouabain (0.5 mM) for 7 h, extracellular reverse transcriptase reverse transcriptase activities were reduced by 87 to 92%. However, the intracellular level of polymerase activities remained almost unchanged (77 to 98% relative to the control). Mouse interferon inhibited the production of MuLV in K3b cells and this antiviral action was not blocked by 0.5 mM-ouabain.

Citing Articles

The cardenolide ouabain suppresses coronaviral replication via augmenting a Na/K-ATPase-dependent PI3K_PDK1 axis signaling.

Yang C, Chang H, Lee Y, Hsu H, Lee S Toxicol Appl Pharmacol. 2018; 356:90-97.

PMID: 30053394 PMC: 7103114. DOI: 10.1016/j.taap.2018.07.028.


Identification of anti-viral activity of the cardenolides, Na/K-ATPase inhibitors, against porcine transmissible gastroenteritis virus.

Yang C, Chang H, Hsu H, Lee Y, Chang H, Chen I Toxicol Appl Pharmacol. 2017; 332:129-137.

PMID: 28438630 PMC: 7103123. DOI: 10.1016/j.taap.2017.04.017.


Human Ebola virus infection in West Africa: a review of available therapeutic agents that target different steps of the life cycle of Ebola virus.

Lai K, Ng W, Cheng F Infect Dis Poverty. 2015; 3:43.

PMID: 25699183 PMC: 4334593. DOI: 10.1186/2049-9957-3-43.


Modulation of influenza virus replication by alteration of sodium ion transport and protein kinase C activity.

Hoffmann H, Palese P, Shaw M Antiviral Res. 2008; 80(2):124-34.

PMID: 18585796 PMC: 2614658. DOI: 10.1016/j.antiviral.2008.05.008.